Tata Power delivers strong Q3 FY26 performance; Q3 FY26 PAT grows to Rs 1,194 crore: 9M FY26 PAT rises to Rs 3,702 crore up 7 % (YoY) ...
Drawing on the teaching and practices of a range of practitioners – from Uta Hagen and Jacques LeCoq, to Rudolf Laban and ...
The researchers found that autophagy at the site of injury reduces levels of stress at the site of the injury, thereby allowing the formation of stem cells. These stem cells activate root regeneration ...
Q2 2026 Earnings Call February 1, 2026 7:01 PM ESTCompany ParticipantsJohn Konstantopoulos - Co-Founder & CEORichard Jarvis ...
Camera-based QR & barcode scanning enables real-time, data-driven automated handwriting at scale WILMINGTON, DE, ...
AegisBridge (AGB TOKEN) completed a phase-based platform architecture optimization, strengthening system stability and ...
MIAMI, FL, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- Pirani announced the release of the 2026 Latin America ...
Based on the literature synthesis and system mapping presented in Section 2.4, a set of design requirements (DRs) was derived ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Phase 3 Study Of T-DXd And Rilvegostomig Versus SoC In Advanced HER2-expressing Biliary Tract Cancer
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
“The positive results of the Phase 3 VERIFY study across the primary and all key secondary endpoints provide compelling evidence of the potential for rusfertide as a first-in-class ...
Previously presented at ESMO 2023, 177 Lu-PSMA-617 prolonged radiographic progression-free survival versus change of androgen receptor pathway inhibitor in taxane-naïve patients with mCRPC in PSMAfore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results